Although the findings were obtained purely from invasive triple-negative breast cancer cells, the results may suggest that TAZ could be investigated as a therapeutic target for the inhibition of the migration of breast cancer cells and metastasis. The gene discussed is WWTR1; the disease is breast carcinoma.